Insider Sale: CGON director Hong Fang Song disposes 713,928 CGON shares
Rhea-AI Filing Summary
CG Oncology director Hong Fang Song (filing signed by attorney-in-fact) reported multiple sales of common stock on 09/03/2025 under a written plan. The Form 4 shows discrete dispositions of 69,695, 30,105, 100, 100 and 613,928 shares, totaling 713,928 shares sold. Two groups are identified as record holders: Charming Jade Limited and Unique Diamond Investments Limited, and Ms. Song discloses indirect beneficial ownership through a chain of entities she ultimately owns. The filing notes weighted average price ranges for portions of the sales and indicates the transactions were made pursuant to a Rule 10b5-1 plan.
Positive
- Transactions executed under a Rule 10b5-1 plan, as indicated by the checked box, which supports preplanned, compliant execution.
- Weighted-average price ranges disclosed for applicable sales, offering transparency about trade pricing.
Negative
- Large insider disposals totaling 713,928 shares were reported on 09/03/2025, which may be perceived negatively by market participants.
- Significant indirect ownership structure (multiple affiliated entities culminating in sole ownership by Ms. Song) concentrates control and may complicate liquidity and governance perceptions.
Insights
TL;DR: Director disposed of 713,928 shares via multiple sales under a 10b5-1 plan, reducing indirect holdings.
The filing documents sizable open-market dispositions totaling 713,928 shares executed 09/03/2025 with reported weighted-average price ranges disclosed for groups of trades. The seller is a director with indirect ownership through multiple related entities, and the Form 4 explicitly checks the box indicating the trades were pursuant to a written 10b5-1 plan. For investors, insider sales are relevant context but this document contains no company performance data or stated purpose for the sales. The transaction sizes and disclosure of affiliated entities are material to assessments of insider liquidity.
TL;DR: Insider sales were structured and disclosed, with beneficial ownership shared across related entities culminating in Song's control.
The report identifies an ownership chain: Charming Jade Limited and Unique Diamond Investments Limited are record holders, ultimately linked through ORI funds and Healthcare Seed Limited, which Ms. Song solely owns. The filing's explicit 10b5-1 indication and weighted-average price disclosures reflect attention to compliance and transparency. The document provides clear provenance of indirect ownership but does not state any change in board status or new agreements beyond the sales reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 69,695 | $27.60 | $1.92M |
| Sale | Common Stock | 30,105 | $28.24 | $850K |
| Sale | Common Stock | 100 | $28.96 | $3K |
| Sale | Common Stock | 100 | $28.99 | $3K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc.
